Alnylam highlights significant pipeline progress and platform innovation at r&d day

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, is hosting an r&d day today in new york city and will also webcast the event. the company plans to showcase its r&d progress and platform innovation, including updates on multiple near- and mid-stage potentially transformative therapies that represent blockbuster opportunities as its pipeline rapidly expands across multiple therapeutic areas. “alnylam is driving the fi.
ALNY Ratings Summary
ALNY Quant Ranking